Skip to the page

Data / Form D filings / RENOVARO INC.

RENOVARO INC.: Form D filings

RENOVARO INC., a health care company in Los Angeles, CA, filed 2 Form D notices with the SEC between 2016 and 2024. The latest, on February 23, 2024, reports $106.8 million sold of a $106.8 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2080 CENTURY PARK EAST, SUITE 906, Los Angeles, CA, 90067
Phone
(305) 918-1980
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1527728

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 23, 2024New notice$106,849,547$106,849,5478Feb 13, 2024sec.gov
Sep 15, 2016New notice$16,500,000$0$16,500,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gregg AltonDirector
Carol BrosgartDirector
Leni BoerenDirector
Karen BrinkDirector
Luisa PucheExecutive Officer
Jayne McNicolDirector
Ruud HendriksDirector
Mark DybulExecutive Officer, Director
James SapirsteinDirector
Avram MillerDirector
Rene SindlevDirector
Francois BinetteExecutive Officer

Other health care companies in California that filed recently

Every Form D from the week of Feb 19, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what RENOVARO INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.